Schedule of Comparison of Basic and Fully Diluted Net Loss Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Earnings Per Share [Abstract]
Net loss before noncontrolling interests	$ (103,238)	$ (56,126)
Net loss attributable to noncontrolling interest	14,255	5,779
Net loss - as reported, attributable to PAVmed Inc.	(88,983)	(50,347)
Series B Convertible Preferred Stock dividends – earned	(281)	(283)
Net loss attributable to PAVmed Inc. common stockholders	$ (89,264)	$ (50,630)
Weighted average common shares outstanding, basic and diluted	89,076,078	77,515,767
Net loss - as reported, attributable to PAVmed Inc.	$ (1.00)	$ (0.65)
Net loss attributable to PAVmed Inc. common stockholders	$ (1.00)	$ (0.65)